73 FR 129 pg. 38235 - Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Working Group Meeting of the NIH Blue Ribbon Panel
Type: NOTICEVolume: 73Number: 129Page: 38235
FR document: [FR Doc. E8-15064 Filed 7-2-08; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Working Group Meeting of the NIH Blue Ribbon Panel
There will be a working group meeting of the NIH Blue Ribbon Panel to advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University Medical Center.
The meeting will be held on Wednesday, July 16, 2008, at the National Institutes of Health, Building 31,31 Center Drive, Floor 6C, Room 6, Bethesda, MD 20892 from approximately 8 a.m. to 1 p.m.
Discussions will focus on risk communications and the general principles and strategies for effective community outreach and engagement.
For further information concerning this meeting contact Ms. Laurie Lewallen, Advisory CommitteeCoordinator, Office of Biotechnology Activities, Office of the Director, National Institutes of Health, Mail Stop Code 7985, Bethesda, MD 20892-7985, telephone 301-496-9838, e-mail lewallla@od.nih.gov.
Background information may be obtained by contacting NIH OBA by email oba@od.nih.gov .
Dated: June 26, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities,National Institutes of Health.
[FR Doc. E8-15064 Filed 7-2-08; 8:45 am]
BILLING CODE 4140-01-P